| |
|
|
|
Asthma: Treatment
Description: A chronic respiratory disease, asthma restricts airways and impairs breathing. Though the cause of asthma is not completely understood, many risk factors increase the chances of developing the disease. Children with infrequent episodic asthma often overcome the condition and gain normal adult lung function. This course will explain the prognosis, treatment options, and classification of pediatric and late onset asthma.
|
COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview
PROGNOSIS
4. Objectives
5. Pediatric Asthma
6. Adult Asthma
7. Progress Check
DRUG DELIVERY ADN PHARMACOKINETICS
8. Objectives
9. Route of Administration
10. Pharmacokinetics
11. Bioavailability
12. pMDIs
13. BAIs and DPIs
14. Nebulizers
15. Progress Check
PHARMACOTHERAPY
16. Objectives
17. Asthma Management
18. Types of Medications
19. Glucocorticosteroids
20. Long-Acting Beta-2 Agonists
21. Other Controller Medications
22. Reliever Medications
23. Progress Check
STEPWISE TREATMENT PLAN PLANS
24. Objectives
25. General Features
26. Case Study 1
27. Case Study 2
28. Infants and Children
29. Progress Check
CONCLUSION
30. Summary
|
|
COURSE OBJECTIVES
Students completing this course should be able
to:
- Explain the natural history of asthma in patients of various age groups
- Describe pediatric asthma's symptoms and long-term prognosis
- Describe the prognosis for those patients with occupational asthma
- Describe common asthma medication administration routes and their pharmacokinetics
- Explain the inhalation delivery devices and their efficacy and safety concerns
- Explain asthma therapy goals and management strategies
- Distinguish between controller and reliever medications
- Describes the actions, advantages, and disadvantages of different pharmacological agents
- List the four asthma severity steps
- Explain how physicians adjust treatment in the stepwise approach to maintain asthma control
|
|
|
|
 SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.
|
|